ArticleFrontiers in oncology2022

Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy.

Xiaoping Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.